Minerva Neurosciences, INC. (NERV) — 10-K/A Filings

All 10-K/A filings from Minerva Neurosciences, INC.. Browse 4 Amended Annual Report reports with AI-powered summaries and risk analysis.

10-K/A Filings (4)

Minerva Neurosciences Files 2024 10-K Amendment — Apr 29, 2025 Risk: low
Minerva Neurosciences, Inc. filed an amendment (No. 2) to its 2024 10-K report on April 29, 2025. The company, incorporated in Delaware with its principal execu
Minerva Neurosciences Files 2024 Annual Report Amendment — Apr 21, 2025 Risk: medium
Minerva Neurosciences, Inc. filed an amendment (10-K/A) on April 21, 2025, for its fiscal year ended December 31, 2024. The company, incorporated in Delaware an
Minerva Neurosciences Files Amended 10-K for Fiscal Year Ended Dec 31, 2023 — Apr 22, 2024 Risk: low
Minerva Neurosciences, Inc. (NERV) filed a Amended Annual Report (10-K/A) with the SEC on April 22, 2024. Minerva Neurosciences, Inc. filed an amended 10-K repo
Minerva Neurosciences Files Amended 10-K for Fiscal Year Ended December 31, 2023 — Feb 26, 2024 Risk: low
Minerva Neurosciences, Inc. (NERV) filed a Amended Annual Report (10-K/A) with the SEC on February 26, 2024. Minerva Neurosciences, Inc. filed an amended 10-K r

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX